A Prospective Clinical Trial of Radiotherapy Combined with PD-1 Inhibitors and GM-CSF, Sequentially Followed by IL-2 (PRaG 2.0) Regimen in Advanced Refractory Solid Tumors

被引：0
|
作者：
Xing, P. [1 ,2 ,3 ]
Yang, J., Sr. [1 ]
Xu, M. [1 ]
Kong, Y. [1 ]
Zhang, J. [1 ]
Zhao, X. [1 ]
Zhang, L. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China
[2] Soochow Univ, Inst Radiotherapy & Oncol, Suzhou, Peoples R China
[3] Suzhou Key Lab Radiat Oncol, Suzhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2336
引用
收藏
页码：E157 / E158
页数：2
相关论文
共 40 条
  • [1] PD-1 inhibitors combined with radiotherapy and GM-CSF, sequentially followed by IL-2 (PRaG 2.0) regimen in advanced refractory solid tumors: A prospective, multicenter, single-arm clinical trial
    Xing, Pengfei
    Yang, Jiabao
    Xu, Meiling
    Wang, Jian
    Han, Dali
    Kong, Yuehong
    Zhang, Junjun
    Zhang, Liyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] PD-1 Inhibitors Combined with Radiotherapy and GM-CSF, Sequentially Followed by IL-2 (PRaG 2.0) Regimen in Metastatic Tumors: A Prospective, Multicenter, Single-Arm Clinical Trial
    Xing, P.
    Yang, J.
    Xu, M.
    Kong, Y.
    Wang, J.
    Wang, J.
    Han, D.
    Zhang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E427 - E427
  • [3] A prospective, multicenter, single-arm clinical trial of PD-1 inhibitors in combination with radiotherapy and GM-CSF, sequentially followed by IL-2 (PRaG 2.0) therapy in advanced refractory solid tumors
    Xing, Pengfei
    Yang, Jiabao
    Kong, Yuehong
    Xu, Meiling
    Wang, Jian
    Wang, Jianshe
    Ma, Yifu
    Zhang, Liyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] PRaG regimens (PD-1 inhibitor combined with radiotherapy and GM-CSF with or not IL-2) rechallenge for patients with acquiring resistance to PD-1/PD-L1 inhibitors in refractory advanced solid tumors
    Xu, Meiling
    Xing, Pengfei
    Kong, Yuehong
    Zhang, Chenyang
    Zhao, Xiangrong
    Zhang, Junjun
    Zhang, Liyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] A Phase II Trial of PD-1 Inhibitors Combined With Multisite Radiotherapy and GM-CSF (PRaG Regimen) for the Treatment of Chemo-Refractory Metastatic Solid Tumors
    Kong, Y.
    Xing, P.
    Zhao, X.
    Chen, G.
    Ma, Y.
    Zhou, L.
    Peng, Q.
    Xu, M.
    Xu, Z.
    Zhang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S117 - S117
  • [6] PD-1 Inhibitor Combined with Radiotherapy and GM-CSF with or not IL-2 (PRaG Regimen) for Advanced Metastatic Non-Small Cell Lung Cancer
    Zhou, W.
    Kong, Y.
    LiYuan, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E402 - E402
  • [7] PD-1 Inhibitor Combined with Radiotherapy and GM-CSF with or not IL-2 (PRaG regimen) in Patients with Microsatellite Stable Metastatic Colorectal Cancer
    Yang, J.
    Xing, P.
    Kong, Y.
    Xu, M.
    Zhang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E154 - E154
  • [8] A phase II trial of PD-1 inhibitor combined with Radiotherapy and GM-CSF (PRaG) in metastatic tumors
    Zhang, L.
    Kong, Y.
    Xing, P.
    Zhao, X.
    Chen, G.
    Ma, Y.
    Zou, L.
    Peng, Q.
    Xu, M.
    Xu, Z.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S492 - S492
  • [9] PD-1 Inhibitor Combined with Hypofractionated Radiotherapy and GM-CSF with or without IL-2 (PRaG Regimens) Rechallenge for Acquiring Resistance to PD-1/ PD-L1 Inhibitor in Advanced Solid Tumors
    Xu, M.
    Xing, P.
    Kong, Y.
    Zhang, C.
    Zhao, X.
    Zhang, J.
    Zhang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E427 - E428
  • [10] A multicenter, phase II trial of RC48-ADC combined with radiotherapy, PD-1/PD-L1 inhibitor, GM-CSF, and sequential IL-2 (PRaG3.0 regimen) for salvage therapy in patients with HER2-expressing advanced solid tumors
    Xu, Meiling
    Chen, Rongzheng
    Xing, Pengfei
    Kong, Yuehong
    Zhao, Xiangrong
    Zhang, Junjun
    Cai, Shang
    Zhang, Liyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
1234